Tower Research Capital (TRC)’s Autonomix Medical AMIX Stock Holding History

Tower Research Capital (TRC)’s Portfolio AMIX Stock Details AMIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.28K	Sell	278 -1	-0.4%	-$9	﹤0.01%	4503
2025 Q4	$3.22K	Buy	279 +25	+10%	+$485	﹤0.01%	4404
2025 Q3	$5.77K	Buy	254 +120	+90%	+$3.14K	﹤0.01%	4202
2025 Q2	$4.4K	Buy	134 +31	+30%	+$1.11K	﹤0.01%	4333
2025 Q1	$3.8K	Buy	103 +59	+134%	+$3.26K	﹤0.01%	4349
2024 Q4	$3.46K	Buy	44 +32	+267%	+$5.66K	﹤0.01%	4651
2024 Q3	$3.01K	Sell	12 -7	-37%	-$2.35K	﹤0.01%	4909
2024 Q2	$7.68K	Buy	19 +15	+375%	+$14.8K	﹤0.01%	4436
2024 Q1	$4.55K	Buy	+4	New	+$6.64K	﹤0.01%	4664

Other funds holding AMIX

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Tower Research Capital (TRC)'s AMIX Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Autonomix Medical (AMIX) stake by 0.36% in Q1 2026, selling an estimated $9 and leaving 278 shares worth $2.28K. The position accounts for ﹤0.01% of the portfolio, ranked #4503.

Tower Research Capital (TRC) first reported a position in AMIX in Q1 2024 and has held it in 9 quarters since. The position peaked at $7.68K in Q2 2024. 10 funds tracked by Wall St. Rank hold AMIX as of Q1 2026.

Tower Research Capital (TRC) held 278 shares of Autonomix Medical worth $2.28K as of Q1 2026.
Tower Research Capital (TRC) sold 1 Autonomix Medical share in Q1 2026, an estimated $9.
Autonomix Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4503 holding.
Tower Research Capital (TRC) first reported a position in Autonomix Medical in Q1 2024 and has held it in 9 quarters since.
Tower Research Capital (TRC)'s Autonomix Medical position peaked at $7.68K in Q2 2024.
10 funds tracked by Wall St. Rank held Autonomix Medical as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.